Methods for AST: diffusion or dilution? (pro s en con s)
|
|
- Margaret Palmer
- 5 years ago
- Views:
Transcription
1 7 th EURL-AR workshop 4-5 April 2013 DTU, Kgs. Lyngby, Denmark Methods for AST: diffusion or dilution? (pro s en con s) Kees Veldman
2 Introduction Work as a senior technician at the Central Veterinary Institute in Lelystad (NL) since 1991 Responsible for the daily routine regarding resistance monitoring (NRL for antibiotic resistance in animals) PhD on plasmid mediated quinolone resistance in Salmonella and E. coli (defense of thesis in 2014)
3 Outline Overview of techniques Methods Dilution & Diffusion Pro s en Con s Conclusions
4 Why perform susceptibility tests? Reasons for susceptibility testing of bacteria Monitoring National programs Diagnostics Focused at treatment
5 Techniques MIC testing Agar dilution (CLSI golden standard) Broth (micro)dilution (ISO-reference method) Diffusion Paper disks Tablets Other tests E-test
6 Agar dilution method
7 Broth dilution method
8 Broth microdilution ISO-Reference method for MIC testing
9 Broth microdilution Different companies Sensititre (Trek Diagnostic Systems, UK) VETMIC (SVA, Uppsala, Sweden) Micronaut (Merlin, Germany)
10 Broth microdilution Performance and reading Manual, semi-automatic or fully automated systems
11 Tablet diffusion (Rosco-Neo sensitabs) Old standard method IST agar Semi-confluent growth (according to ICS, Ericsson & Sherris, 1971) Criteria: Rosco manual (Dutch CRG, 2002) Other methods (Kirby/Bauer EUCAST) MH agar Confluent growth Criteria: Rosco criteria derived from to CLSI/EUCAST (validated??)
12 Tablet diffusion (Rosco-Neo sensitabs) Shift to other packages and dispensers
13 Disk diffusion (paper disks) Method Disk diffusion test (according to EUCAST or CLSI) Media: MH agar Antibiotics: paper disks different loads! Inoculum: confluent Criteria: EUCAST or CLSI
14 Zone diameter sizes Reading: Manual (calipers) Semi-automated (with electronic calipers) Fully automated by image analyses with a camera
15 Epsilometer test Strips E-test (Bio-Merieux) M.I.C.E. test (Oxoid)
16 Fully automated susceptibility (and identification) systems Phoenix (Becton-Dickinson) Microscan WalkAway System Sensititre ARIS Vitek (2) System
17 Distribution of MIC s
18 Distribution of inhibtion zones
19 Linear regression
20 Critical steps in susceptibility testing should be standardized at all times Inocula Media Antibiotics End point determination
21 Inocula Standard: 0.5 McFarland Using a turbidometer/ densitometer
22 Media for disk diffusion Easy growers: Mueller Hinton agar (both CLSI and EUCAST) Fastidious bacteria: EUCAST: MH-F agar (= MH agar + 5 % sheep blood + % NAD) for all difficult growers, including campylobacters CLSI: MH agar + 5% defribinated sheep blood for Streptococci and Pasteurellae MH agar % lysed horse blood for Listeria Chocolate Mueller Hinton agar for APP and HSO
23 Media for broth microdilution Easy growing bacteria: ISO, EUCAST and CLSI : Cation-adjusted Mueller Hinton Broth(CAMHB) Fastidious bacteria: ISO, EUCAST and CLSI: CAMHB + Lysed Horse Blood for testing streptococci, campylobacter, H.influenzae, Pasteurella spp and others CLSI (veterinary): Veterinary Fastidious Medium for APP and HSO
24 Antibiotics Diffusion Choose a reliable company for tablets or disks Use the correct load Dilution Choose a reliable company for the microtiter plates Choose a suitable panel Buy a custom made panel
25 End point reading Diffusion Difficult antibiotics Sulfanomides and trimethoprim: 80% growth inhibition Penicillin and staphylococci : sharp edge means resistant Dilution Sulfanomides and trimethoprim: 80% growth inhibition Skips are ignored unless...
26 Guidelines Diffusion EUCAST disk diffusion method (new European standard) CLSI several documents (veterinair + human) Dilution CLSI several documents ISO document :2006
27 CLSI Recommend QC-ranges of reference strains Clinical breakpoints are recommended: Susceptible Intermediate resistant Resistant
28 EUCAST Recommend QC-ranges of reference strains Both clinical breakpoint and epidemiological cut-off values Cut-off values defined by EUCAST by wild-type distribution Strictly for monitoring purposes! All bacteria with MIC above WT are defined as NWT, but are often called resistant
29 Epidemiological cut-off value & clinical breakpoints
30 Pro s en con s dilution Pro s Internationally standardized Hard (quantitative) figures (MIC s) Reproducible and robust Automated systems available Con s Expensive Requires more lab facilities
31 Pro s en con s diffusion Pro s Cheap Easy to perform Con s Results derived from MICs Many methods available (e.g. ISO, CLSI etc) Less robust and reproducible??
32 Summary Parameter Dilution Diffusion Validated method and criteria available available Information hard figures (MIC s) derived MIC s Reproducibility and robustness high medium Potential for automation high only for reading Costs expensive cheap Equipment required variable minor Laborious depending on equipment depending on equipment
33 Dilution or diffusion Choice is dependent of: Purpose of the test Monitoring Diagnostics Budget Lab facilities Frequency of testing
34 Discussion Dilution or diffusion? No confusion, standardize your test carefully!
35 Standardization means: 1 methods for all labs (dilution or diffusion) Identical concentration ranges/disk loads/media/inocula 1 set of interpretive criteria/cut-off values/breakpoints Internal and external QAS Only then results are truly comparable
36 ECDC ringtrials for Salmonella Enternet lab s
37 Acknowledgements Project group for Antibiotic Resistance (CVI) Prof. Dr D. Mevius Drs C. Dierikx Mrs M. Japing Mr J. Testerink Mrs A. van Essen Mr A. Kant
38 Microbroth dilution (MBD) vs Disk diffusion Robert Skov Statens Serum Institut / EUCAST
39 Reason for making a standard To have ONE value to measure against Needed for manufacturers of AST devices! MIC is the natural choice as clinical data is correlated to MIC when establishing the efficacy of the antibiotics MBD was chosen not the least because it is the most widely used! ISO (2006) Non-fastidious organisms only!
40 For fastidious organisms no gold standard has been defined CLSI: CAMHB % LHB (streptococci, campylobacter) HTM (haemophilus) EUCAST:
41 EUCAST AST of fastidious organisms MH-F is Mueller-Hinton agar (or broth) with 5% (mechanically) defibrinated horse blood and 20 mg/l β-nad. Developed for: Haemophilus influenzae Moraxella catarrhalis Streptococci A, B, C, G and viridans group Streptococcus pneumoniae Campylobacter jejuni and C. coli Listeria monocytogenes Corynebacterium spp. Pasteurella multocida
42 Do MBD always give the right value/answer? Are MBD always better than all other systems? Especially DD
43 Well calibrated MBD has a precision of +/- one dilution i.e. when close to a breakpoint it will sometimes give a false result MBD NEEDS to be well calibrated and quality controlled just as well as all other systems! The discrete values of MBD mask some of the variation (makes it appear less variable than DD)
44 Ciprofloxacin (MBD) QC readings from the manufacturer for ciprofloxacin were at the lower limit of the QC range < Resistance Mechanism None qnr QRDR aac6
45 40 Ofloxacin Resistance Mechanism None qnr QRDR aac6 5 0 <
46 Repeated MICs for 17 retested isolates Ceftaroline for S. aureus Isolate Etest BMD Mean BMD "True MIC"
47 MBD is fairly expensive i.e. truncated ranges are often used May need alternative systems for testing other antibiotics than is on your panel
48 Disk diffusion Just like with MIC dependant of a range of factors Needs to be well calibrated! DD is not suitable for all drug bug combinations and can only be used where developed Usually very high correlation between MBD and DD Salmonella and ciprofloxacin is an example where DD still needs refinement this is not clear from the present table will be fixed
49
50 Stability of DD 10 years QC data displayed as a yearly median value for all Swedish laboratories
51 Cipro 5 vs 128 salmonellae tested 4 times Breakpoint for susceptibility in CLSI M100 Zone diameter Resistance mechanism none qnr QRDR aac
52
53 Tetracycline 30 μg vs. MIC S. aureus, 172 clinical isolates MIC (mg/l) >8 8 No of isolates Inhibition zone diameter (mm) Breakpoints ECOFF MIC S 1, R>2 mg/l WT 1 mg/l Zone diameter S 22, R<19 mm
54 40 Ciprofloxacin 5 µg vs. MIC, Campylobacter jejuni and coli 57 clinical isolates tested in duplicate No of isolates ECOFF: WT 1 mg/l Inhinition zone diameter (mm) NL and FI isolates read in Växjö. All isolates tested in duplicate on in-house MH-F plates from Oxoid and BBL MH.
55 70 S. aureus vs. Ceftaroline 5 µg (Oxoid and MAST disks) 17 selected isolates tested x15 (N=323) No of readings Inhibition zone diameter (mm)
56 DD hold significant advantages Cheaper Always provide the full range DD gives continous values whereas MIC only gives discrete values (1,2,4.) Inexpensive to test alternative antibiotics
57 Provided well calibrated both MBD and DD gives reproducible results Do include some variation! MBD is a natural choice for gold standard DD produces equally good results For those drug/bug combinations where it is developed Both systems have high reproducibility Provided well calibrated DD is cheaper
Methods for colistin testing What works and what does not? Erika Matuschek, Ph D EUCAST Development Laboratory, EDL
Methods for colistin testing What works and what does not? Erika Matuschek, Ph D EUCAST Development Laboratory, EDL 3 rd joint meeting on AMR in Salmonella and Campylobacter, Copenhagen 7 April 2017 Antimicrobial
More informationEUCAST Frequently Asked Questions. by author. Rafael Cantón Hospital Universitario Ramón y Cajal, Madrid, Spain EUCAST Clinical Data Coordinator
EUCAST Frequently Asked Questions Rafael Cantón Hospital Universitario Ramón y Cajal, Madrid, Spain EUCAST Clinical Data Coordinator Erika Matuschek EUCAST Development Laboratory, Växjö Sweden Monday 24
More informationWhat is new in EUCAST South Africa, May, Gunnar Kahlmeter EUCAST Technical Data Coordinator and Webmaster Sweden
What is new in EUCAST 2016 17 South Africa, May, 2016 Gunnar Kahlmeter EUCAST Technical Data Coordinator and Webmaster Sweden What is new in EUCAST 2016/17? New organisms with breakpoints (Addendum 2016)
More informationReport on susceptibility of Salmonella serotypes in Belgium Vicky Jasson
CODA-CERVA Report on susceptibility of Salmonella serotypes in Belgium 2014. Vicky Jasson Veterinary and Agrochemical Research Centre 1 Introduction Salmonella is one of the most important bacterial zoonotic
More informationSteven D. Brown* and Maria M. Traczewski. The Clinical Microbiology Institute, 9725 SW Commerce Circle, Wilsonville, Oregon 97070
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, May 2010, p. 2063 2069 Vol. 54, No. 5 0066-4804/10/$12.00 doi:10.1128/aac.01569-09 Copyright 2010, American Society for Microbiology. All Rights Reserved. Comparative
More informationWhy some tests are no longer recommended
8 th July 2014 Why some tests are no longer recommended Robin A Howe, Cardiff, UK Antimicrobial use in Primary Care Tests that are no longer recommended Burkholderia cepacia complex testing Stenotrophomonas
More informationACCEPTED. Comparison of disk diffusion and agar dilution methods for erythromycin and
AAC Accepts, published online ahead of print on January 00 Antimicrob. Agents Chemother. doi:./aac.000-0 Copyright 00, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights
More informationTable 1. Antifungal Breakpoints for Candida. 2,3. Agent S SDD or I R. Fluconazole < 8.0 mg/ml mg/ml. > 64 mg/ml.
AUSTRALIAN ANTIFUNGAL SUSCEPTIBILITY DATA 2008-2011 Part 1: The Yeasts In this article, an update of recent changes to the CLSI antifungal standards for susceptibility testing of yeasts is presented. We
More informationMupirocin Rationale for the EUCAST clinical breakpoints, version th July 2010
Mupirocin Rationale for the EUCAST clinical breakpoints, version 1.0 6 th July 2010 Foreword EUCAST The European Committee on Antimicrobial Susceptibility Testing (EUCAST) is organised by the European
More informationReceived 30 March 2005; returned 16 June 2005; revised 8 September 2005; accepted 12 September 2005
Journal of Antimicrobial Chemotherapy (2005) 56, 1047 1052 doi:10.1093/jac/dki362 Advance Access publication 20 October 2005 Evaluation of PPI-0903M (T91825), a novel cephalosporin: bactericidal activity,
More informationAST issues of polymyxins and their implications for the routine laboratory
AST issues of polymyxins and their implications for the routine laboratory Christian G. Giske, MD/PhD Chief consultant physician/associate professor Chairman of EUCAST Karolinska Institute and University
More informationSpectrum of vancomycin and susceptibility testing
Spectrum of vancomycin and susceptibility testing Olivier Denis Service de Microbiologie Laboratoire de bactériologie Service de Microbiologie Hôpital Erasme Glycopeptides Vancomycin 1958 < Amycolatopsis
More informationCefotaxime Rationale for the EUCAST clinical breakpoints, version th September 2010
Cefotaxime Rationale for the EUCAST clinical breakpoints, version 1.0 26 th September 2010 Foreword EUCAST The European Committee on Antimicrobial Susceptibility Testing (EUCAST) is organised by the European
More informationReporting blood culture results to clinicians: MIC, resistance mechanisms, both?
Reporting blood culture results to clinicians: MIC, resistance mechanisms, both? Christian G. Giske, MD, PhD Senior Consultant Physician/Associate Professor Department of Clinical Microbiology Karolinska
More informationCorrespondence should be addressed to Irene Burckhardt;
Hindawi BioMed Research International Volume 217, Article ID 4174168, 7 pages http://dx.doi.org/1.1155/217/4174168 Research Article Identification of Streptococcus pneumoniae: Development of a Standardized
More informationAttachment 12 URGENT FIELD SAFETY REMOVAL FSCA3193. ETEST Ceftriaxone TXL32 (Ref , ) FOAM packaging
16 January 2017 Attachment 12 URGENT FIELD SAFETY REMOVAL FSCA3193 ETEST Ceftriaxone TXL32 (Ref. 507058, 507018) FOAM packaging Dear This letter is intended for all ETEST Ceftriaxone TXL32 (Ref. 507058,
More informationReceived 21 April 1997/Returned for modification 30 June 1997/Accepted 28 August 1997
JOURNAL OF CLINICAL MICROBIOLOGY, Dec. 1997, p. 3258 3263 Vol. 35, No. 12 0095-1137/97/$04.00 0 Copyright 1997, American Society for Microbiology Comparison of Agar Dilution, Broth Microdilution, E-Test,
More informationAntifungal susceptibility testing: Which method and when?
Antifungal susceptibility testing: Which method and when? Maiken Cavling Arendrup mad@ssi.dk SSI & Juan Luis Rodriguez Tudela jlrtudela@isciii.es ISCIII Agenda Summary of current standards and selected
More informationURGENT FIELD SAFETY NOTICE FSCA3193. Etest Ceftriaxone TXL32 (Ref , ) SPB Packaging
16 January 2017 Attachment 3 URGENT FIELD SAFETY NOTICE FSCA3193 Etest Ceftriaxone TXL32 (Ref. 412302, 412303) SPB Packaging Dear This letter is intended for all ETEST Ceftriaxone TXL32 (Ref. 412302, 412303)
More informationCefuroxime iv Rationale for the EUCAST clinical breakpoints, version th September 2010
Cefuroxime iv Rationale for the EUCAST clinical breakpoints, version 1.0 26 th September 2010 Foreword EUCAST The European Committee on Antimicrobial Susceptibility Testing (EUCAST) is organised by the
More informationResistance among Streptococcus pneumoniae Clinical Isolates by Use of the E Test
JOURNAL OF CLINICAL MICROBIOLOGY, Jan. 1994, p. 159-163 0095-1137/94/$04.00+0 Copyright 1994, American Society for Microbiology Vol. 32, No. 1 Detection of Penicillin and Extended-Spectrum Cephalosporin
More informationScreening and detection of carbapenemases
Screening and detection of carbapenemases For many isolates with carbapenemases the MICs of carbapenems are around the susceptible breakpoint making resistance difficult to detect - particularly with automated
More informationEUCAST breakpoints. Paul M. Tulkens. Representative of ISC to EUCAST ( ) Member of the EUCAST steering committee ( )
31 May 2012 ISP - WIV, Brussels, Belgium 1 EUCAST breakpoints 31 May 2012 Paul M. Tulkens Representative of ISC to EUCAST (2006 - ) Member of the EUCAST steering committee (2008-2010) Co-Founder and Past-President
More information(and breakpoint table, MIC and. by author. ESCMID Online Lecture Library. conventions) ECCMID 2011, Milan
EUCAST definitions (and breakpoint table, MIC and zone distribution ib ti website ECCMID 2011, Milan conventions) Derek Brown Clinically susceptible/resistant A microorganism is defined as susceptible
More informationMethodological and interpretative problems in antimicrobial susceptiblity tests of P. aeruginosa
Methodological and interpretative problems in antimicrobial susceptiblity tests of P. aeruginosa Y. Glupczynski Laboratoire de bactériologie Cliniques Universitaires UCL de Mont-Godinne Université Catholique
More informationESCMID Online Lecture Library. by author
Factors influencing the results of metronidazole resistance testing Elisabeth Nagy Institute of Clinical Microbiology, University of Szeged, National Anaerobe Reference Laboratory, Szeged, Hungary Postgraduate
More informationReceived 13 September 2006/Returned for modification 6 November 2006/Accepted 26 December 2006
JOURNAL OF CLINICAL MICROBIOLOGY, Mar. 2007, p. 858 864 Vol. 45, No. 3 0095-1137/07/$08.00 0 doi:10.1128/jcm.01900-06 Copyright 2007, American Society for Microbiology. All Rights Reserved. Correlation
More informationRapid susceptibility testing: new phenotypic and non-wgs genotypic approaches
Rapid susceptibility testing: new phenotypic and non-wgs genotypic approaches BSAC Spring Conference 2018 Next generation Antimicrobial Susceptibility Testing of Bacteria Oskar Ekelund, MD Clinical Microbiology
More informationDiscussion points CLSI M100 S19 Update. #1 format of tables has changed. #2 non susceptible category
Discussion points 2009 CLSI M100 S19 Update Nebraska Public Health Laboratory Changes most important to routine antimicrobial susceptibility testing. Documents available Janet Hindler discussion slide
More informationReport: antimicrobial resistance in commensal E. coli from poultry, pigs, cows and veal calves. 2013
Veterinary and Agrochemical Research Centre Report: antimicrobial resistance in commensal E. coli from poultry, pigs, cows and veal calves. 2013 1 Introduction Commensal E. coli are regarded as general
More informationCase Studies, or Verification Vignettes
Case Studies, or Verification Vignettes 1 Vignette #1 Change from One Automated AST to Another Your lab is changing from one FDA-cleared automated AST to another Is a verification study required? 2 Yes
More informationReport on the Japanese Veterinary Antimicrobial Resistance Monitoring System
Report on the Japanese Veterinary Antimicrobial Resistance Monitoring System 2014 2015 National Veterinary Assay Laboratory Ministry of Agriculture, Forestry and Fisheries 2018 Contents Introduction...
More informationBACTERIOLOGY PROFICIENCY TESTING PROGRAM
BACTERIOLOGY PROFICIENCY TESTING PROGRAM Comprehensive Category January 14, 2013 If you have any questions or comments, please contact either: Dr. Wendy Archinal Dr. Kimberlee Musser Phone: (518) 474-4177
More informationInsert for Kit 98006/98010/ KPC/Metallo-B-Lactamase Confirm Kit KPC+MBL detection Kit KPC/MBL and OXA-48 Confirm Kit REVISION: DBV0034J
Insert for Kit 98006/98010/98015 KPC/Metallo-B-Lactamase Confirm Kit KPC+MBL detection Kit KPC/MBL and OXA-48 Confirm Kit REVISION: DBV0034J DATE OF ISSUE: 09.02.2017 LANGUAGE: English FOR IN VITRO DIAGNOSTIC
More informationIn vitro assessment of dual drug combinations to inhibit growth of Neisseria gonorrhoeae
AAC Accepted Manuscript Posted Online 26 January 2015 Antimicrob. Agents Chemother. doi:10.1128/aac.04127-14 Copyright 2015, American Society for Microbiology. All Rights Reserved. 1 2 In vitro assessment
More informationAn evaluation of 2.0 McFarland Etest method for detection of heterogeneous vancomycin-intermediate Staphylococcus aureus
Asian Biomedicine Vol. 4 No. 1 February 2010; 141-145 Brief communication (Original) An evaluation of 2.0 McFarland Etest method for detection of heterogeneous vancomycin-intermediate Staphylococcus aureus
More informationLaboratory CLSI M100-S18 update. Paul D. Fey, Ph.D. Associate Professor/Associate Director Josh Rowland, M.T. (ASCP) State Training Coordinator
Nebraska Public Health Laboratory 2008 CLSI M100-S18 update Paul D. Fey, Ph.D. Associate Professor/Associate Director Josh Rowland, M.T. (ASCP) State Training Coordinator Agenda Discuss 2008 M100- S18
More informationReceived 12 December 2010/Returned for modification 5 January 2011/Accepted 16 March 2011
JOURNAL OF CLINICAL MICROBIOLOGY, May 2011, p. 1765 1771 Vol. 49, No. 5 0095-1137/11/$12.00 doi:10.1128/jcm.02517-10 Copyright 2011, American Society for Microbiology. All Rights Reserved. Multicenter
More informationVancomycin Rationale for the EUCAST clinical breakpoints, version June 2010
Vancomycin Rationale for the EUCAST clinical breakpoints, version 2.1 17 June 2010 Introduction The glycopeptides are a class of agents composed of amino acid residues and attached sugars. Glycopeptides
More informationResistance to linezolid in enterococci and staphylococci referred to the national reference laboratory
Resistance to linezolid in enterococci and staphylococci referred to the national reference laboratory Dr Danièle Meunier, AMRHAI BSAC - Antimicrobial Susceptibility Testing User Days Oxazolidinone Linezolid
More informationComparision of Antibiotic Susceptibility Testing As Per CLSI and Eucast Guidelines for Gram Negative Bacilli
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 15, Issue 7 Ver. X (July. 2016), PP 01-05 www.iosrjournals.org Comparision of Antibiotic Susceptibility
More informationGuidance on screening and confirmation of carbapenem resistant Enterobacteriacae (CRE) December 12, 2011
Guidance on screening and confirmation of carbapenem resistant Enterobacteriacae (CRE) December 12, 2011 Objectives: To discuss the guidelines for detection of CRE in the laboratory setting. To review
More informationLABORATORY BASED DST FOR BEDAQUILINE AND INTRODUCTION IN COUNTRIES
LABORATORY BASED DST FOR BEDAQUILINE AND INTRODUCTION IN COUNTRIES NDWG Annual meeting 2015, Cape Town, South Africa Rigouts Leen, Institute of Tropical Medicine, Antwerp, Belgium 1 Bedaquiline (BDQ) Sirturo
More informationBACTERIOLOGY PROFICIENCY TESTING PROGRAM
BACTERIOLOGY PROFICIENCY TESTING PROGRAM Comprehensive Category January 19, 2016 If you have any questions or comments, please contact either: Dr. Wendy Archinal Nellie Dumas Dr. Kimberlee Musser Phone:
More informationAffinity of Doripenem and Comparators to Penicillin-Binding Proteins in Escherichia coli and ACCEPTED
AAC Accepts, published online ahead of print on February 00 Antimicrob. Agents Chemother. doi:./aac.01-0 Copyright 00, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights
More informationVeterinary and Agrochemical Research Centre
Veterinary and Agrochemical Research Centre Report on susceptibility of Salmonella serotypes in Belgium. P. Butaye Susceptibility of Salmonella strains was assessed by MIC determination using Sensititer
More informationUpdate on CLSI and EUCAST
Update on CLSI and EUCAST 1 Completed work» Cephalosporin breakpoints for Enterobacteriaceae ESBL screens MIC versus resistance mechanism» Carbapenem breakpoints for Enterobacteriaceae Modified Hodge Test»
More informationANTIMICROBIAL RESISTANCE PROFILING OF SALMONELLA ENTERICA DISTINCT SEROTYPES ISOLATED FROM PORK IN SÃO PAULO
ANTIMICROBIAL RESISTANCE PROFILING OF SALMONELLA ENTERICA DISTINCT SEROTYPES ISOLATED FROM PORK IN SÃO PAULO Luisa Z. Moreno 1, Vasco T.M. Gomes 1, Ana Paula S. Silva 1, Maria Gabriela X. Oliveira 1, Carlos
More informationDetecting Carbapenemase-Producing Enterobacteriaceae: why isn t there a single best method?
Detecting Carbapenemase-Producing Enterobacteriaceae: why isn t there a single best method? Professor Neil Woodford Antimicrobial Resistance & Healthcare Associated Infections (AMRHAI) Reference Unit Crown
More informationAntimicrobial activity of Terminalia chebula
, ISSN 2249 4340 Vol. 1, No. 2, pp. 175-179, September 2011 RESEARCH ARTICLE Antimicrobial activity of Terminalia chebula M. Golam MOSTAFA, Mahdia RAHMAN, M. Manjurul KARIM* Department of Microbiology,
More informationVoriconazole Rationale for the EUCAST clinical breakpoints, version March 2010
Voriconazole Rationale for the EUCAST clinical breakpoints, version 2.0 20 March 2010 Foreword EUCAST The European Committee on Antimicrobial Susceptibility Testing (EUCAST) is organised by the European
More informationNONFERMENTING GRAM NEGATIVE RODS. April Abbott Deaconess Health System Evansville, IN
NONFERMENTING GRAM NEGATIVE RODS April Abbott Deaconess Health System Evansville, IN OBJECTIVES Discuss basic limitations to assessing carbapenem resistance in nonfermenting GNRs Discuss antimicrobial
More informationT&T WG. June 2018 San Diego, CA
T&T WG June 2018 San Diego, CA Co-Chairs Jana Swenson Shelley Campeau Secretary Carey-Ann Burnham Members Andrea Ferrell Janet Hindler Melissa Jones Peggy Kohner Dyan Luper Linda Mann Susan Munro Barth
More informationBACTERIOLOGY PROFICIENCY TESTING PROGRAM
BACTERIOLOGY PROFICIENCY TESTING PROGRAM Comprehensive Category September 6, 2016 If you have any questions or comments, please contact either: Dr. Wendy Archinal Nellie Dumas Dr. Kimberlee Musser Phone:
More informationIn-House Standardization of Carba NP Test for Carbapenemase Detection in Gram Negative Bacteria
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 7 Number 01 (2018) Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2018.701.342
More informationORIGINAL ARTICLE. Pneumococcal acute otitis media in children
ORIGINAL ARTICLE Pneumococcal acute otitis media in children G. Kouppari 1, A. Zaphiropoulou 1, G. Stamos 1, V. Deliyianni 1, N. Apostolopoulos 2 and N. J. Legakis 3 1 Microbiology Laboratory, 2 ENT Department
More informationExpert rules. for Gram-negatives
Academic Perspective in Expert rules Emerging Issues of Resistance in Gram-ve Bacteria for Gram-negatives Trevor Winstanley Sheffield Teaching Hospitals Presented on behalf of David Livermore University
More informationPerformance of Various Testing Methodologies for Detection of Heteroresistant Vancomycin-Intermediate Staphylococcus aureus in Bloodstream Isolates
JOURNAL OF CLINICAL MICROBIOLOGY, Apr. 2011, p. 1489 1494 Vol. 49, No. 4 0095-1137/11/$12.00 doi:10.1128/jcm.02302-10 Copyright 2011, American Society for Microbiology. All Rights Reserved. Performance
More informationMulti-drug Resistant Serotype 19A Pneumococci in Toronto
TML Lab Rounds January 17, 2008 Multi-drug Resistant Serotype 19A Pneumococci in Toronto The Role of the Microbiology Lab Susan M. Poutanen, MD, MPH, FRCPC Microbiologist/ID Consultant, TML/MSH Assistant
More informationControversial Issues in Susceptibility Testing: Point/Counterpoint. April N. Abbott, PhD D(ABMM) Romney M. Humphries, PhD D(ABMM)
Controversial Issues in Susceptibility Testing: Point/Counterpoint April N. Abbott, PhD D(ABMM) Romney M. Humphries, PhD D(ABMM) Disclosures RMH: Funding from BD, biomerieux, Beckman-Coulter, GenMark,
More informationDetecting CRE. what does one need to do?
5 th ICAN Conference, Harare 4 th November 2014 Room 2: 10:30-12:00 Detecting CRE (Carbapenem-resistant Enterobacteriaceae) what does one need to do? Dr Nizam Damani Associate Medical Director Infection
More informationS. aureus NCTC 6571, E. coli NCTC (antibiotic
ISO Sensitivity Test Agar Code: KM1204 A semi-defined nutritionally rich sensitivity medium. It is composed of specially selected peptones with a small amount of glucose, solidified with a very pure agar
More informationRAPID COMMUNICATION. Maura S. de Oliveira, I Silvia Figueiredo Costa, II Ewerton de Pedri, II Inneke van der Heijden, II Anna Sara S.
RAPID COMMUNICATION The minimal inhibitory concentration for sulbactam was not associated with the outcome of infections caused by carbapenem-resistant Acinetobacter sp. treated with ampicillin/sulbactam
More informationEvaluation of Antibacterial Effect of Odor Eliminating Compounds
Evaluation of Antibacterial Effect of Odor Eliminating Compounds Yuan Zeng, Bingyu Li, Anwar Kalalah, Sang-Jin Suh, and S.S. Ditchkoff Summary Antibiotic activity of ten commercially available odor eliminating
More informationMALDI-TOF MS: a new tool to rapidly assess antibiotic susceptibility
MALDI-TOF MS: a new tool to rapidly assess antibiotic susceptibility Sören Schubert, MD Max von Pettenkofer-Institut Ludwig-Maximilians-University (LMU) Munich, Germany Learning Objectives After this presentation,
More informationThe microbial diagnosis of infective endocarditis (IE)
The microbial diagnosis of infective endocarditis (IE) Pierrette Melin Medical Microbiology pm-chulg sbimc 10.05.2007 1 Introduction for diagnosis Review of microbiological investigation of IE and perspectives
More informationCRE Laboratory Detection & Recap of ARO Consensus Conference
CRE Laboratory Detection & Recap of ARO Consensus Conference S A S K P I C C O N F E R E N C E S E P T E M B E R 2 6 TH, 2 0 1 4 D R. J E S S I C A M I N I O N, M D M S C F R C P C D(A B M M ) M E D I
More informationBD Diagnostics Integrated Solutions. Identification and Antimicrobial Susceptibility Testing Diagnostics
BD Diagnostics Integrated Solutions Identification and Antimicrobial Susceptibility Testing Diagnostics Table of contents The threat of antimicrobial resistant bacteria 4 BD Phoenix TM Emerge 5 Financing
More informationAntibiotic Resistance Pattern of Blood and CSF Culture Isolates At NHLS Academic Laboratories (2005)
Antibiotic Resistance Pattern of Blood and CSF Culture Isolates At NHLS Academic Laboratories (2005) Streptococcus pneumoniae (SP) Blood Culture Isolates Penicillin intermediate Penicillin Cefotaxime 336
More informationSynergy of beta-lactams with vancomycin against methicillin-resistant. Staphylococcus aureus: correlation of the disk diffusion and the
JCM Accepted Manuscript Posted Online 16 December 2015 J. Clin. Microbiol. doi:10.1128/jcm.01779-15 Copyright 2015, American Society for Microbiology. All Rights Reserved. 1 2 3 Synergy of beta-lactams
More informationFÜR RISIKOBEWERTUNG BUNDESINSTITUT. Proposal for a common Staphylococci panel design. Andreas Schroeter, BfR Antonio Battisti, ISS Dik Mevius, CIDC
BUNDESINSTITUT FÜR RISIKOBEWERTUNG Proposal for a common Staphylococci panel design Andreas Schroeter, BfR Antonio Battisti, ISS Dik Mevius, CIDC 1. Method 2. Requirements 3. Common MRSA plate format 4.
More informationValidation of Vitek version 7.01 software for testing staphylococci against vancomycin
Diagnostic Microbiology and Infectious Disease 43 (2002) 135 140 www.elsevier.com/locate/diagmicrobio Validation of Vitek version 7.01 software for testing staphylococci against vancomycin P.M. Raney a,
More informationHaemophilus influenzae from four laboratories in one Canadian City
Journal of Antimicrobial Chemotherapy (988), -9 Haemophilus influenzae from four laboratories in one Canadian City Julie Righter" and Ingrid Luchstnger* 'Department of Microbiology, University of Toronto;
More informationÖrebro University Hospital
Örebro University Hospital Department of Laboratory Medicine Susanne Jacobsson Date: 2015-02-18 Page 1 (8) Neisseria meningitidis 2014 Annual report concerning serogroup, genosubtype and antibiotic susceptibility
More informationDetermination of MIC & MBC
1 Determination of MIC & MBC Minimum inhibitory concentrations (MICs) are defined as the lowest concentration of an antimicrobial that will inhibit the visible growth of a microorganism after overnight
More informationAntibacterial activity and mechanism of ZnO nanoparticles on C. jejuni
Antibacterial activity and mechanism of ZnO nanoparticles on C. jejuni Yiping He Yanping Xie Molecular Characterization of Foodborne Pathogens Research Unit, USDA-ARS ZnO It is stable under high temperatures
More informationAntimicrobial effects of pine essential oil against Listeria monocytogenes
University of Arkansas, Fayetteville ScholarWorks@UARK Biological and Agricultural Engineering Undergraduate Honors Theses Biological and Agricultural Engineering 5-2015 Antimicrobial effects of pine essential
More informationTonsil Lung
BIAXIN FILMTAB - clarithromycin tablet, film coated BIAXIN XL FILMTAB - clarithromycin tablet, film coated, extended release BIAXIN - clarithromycin granule, for suspension Abbott Laboratories To reduce
More informationNEW ANTI-INFECTIVE AGENTS IN 2003 : SPECTRUM AND INDICATIONS. 20th Symposium (spring 2003) Thursday May 22nd 2003
NEW ANTI-INFECTIVE AGENTS IN 2003 : SPECTRUM AND INDICATIONS 20th Symposium (spring 2003) Thursday May 22nd 2003 The slides presented at this meeting are available on this site as "Web slide shows" and
More informationGBS Screening, diagnosis and clinically relevant resistance
GBS Screening, diagnosis and clinically relevant resistance Pierrette Melin National Reference Centre for GBS Medical Microbiology, University Hospital of Liege 1 Background Evolution of culture methods
More informationon November 3, 2018 by guest
JOURNAL OF CLINICAL MICROBIOLOGY, June 2007, p. 1811 1820 Vol. 45, No. 6 0095-1137/07/$08.00 0 doi:10.1128/jcm.00134-07 Copyright 2007, American Society for Microbiology. All Rights Reserved. Multicenter
More informationMongolia September 2012
MVZ DORTMUND - Dr.Eberhard u. Partner - MICROBIOLOGY MALDI-TOF (MS) evaluation for routine diagnostics MIKROBIOLOGY www.labmed.de / mikro@labmed.de Mongolia September 2012 accreditation since april 2003
More informationAlloiococcus otitidis: a neglected bacterium in otitis media
Alloiococcus otitidis: a neglected bacterium in otitis media School of Health Sciences University of Newcastle HAPS Immunology and Genetics Newcastle Australia The team in alphabetical order Chris Ashhurst-Smith
More informationClarithromycin Tablets, USP 250 mg and 500 mg
Clarithromycin Tablets, USP 250 mg and 500 mg Rx only To reduce the development of drug-resistant bacteria and maintain the effectiveness of clarithromycin and other antibacterial drugs, clarithromycin
More informationLaboratory Protocol. November 2017 Version 3. Henrik Hasman, Yvonne Agersø and Lina M Cavaco (DTU Food)
Laboratory Protocol Validation of selective MacConkey agar plates supplemented with 1 mg/l cefotaxime for monitoring of ESBL- and AmpCproducing E. coli in meat and caecal samples November 2017 Version
More informationReport: antimicrobial resistance in commensal Enterococcus spp. from poultry, pigs, cows and veal calves
Veterinary and Agrochemical Research Centre Report: antimicrobial resistance in commensal Enterococcus spp. from poultry, pigs, cows and veal calves P. Butaye 1 Introduction Enterococci are regarded as
More informationAcademic Perspective in. David Livermore Prof of Medical Microbiology, UEA Lead on Antibiotic resistance PHE
Academic Perspective in Emerging No, we can t Issues treat of carbapenemase Resistance and ESBL in Gram-ve producers Bacteria based on MIC David Livermore Prof of Medical Microbiology, UEA Lead on Antibiotic
More informationA new selective blood agar medium for Streptococcus pyogenes and other haemolytic streptococci
J. clin. Path. (1964), 17, 231 A new selective blood agar medium for Streptococcus pyogenes and other haemolytic streptococci E. J. L. LOWBURY, A. KIDSON, AND H. A. LILLY From the Medical Research Council
More informationMonodox Doxycycline Monohydrate Capsules Aqua Pharmaceuticals, LLC Revised: January 2012 Rx only
To reduce the development of drug-resistant bacteria and maintain the effectiveness of Monodox and other antibacterial drugs, Monodox should be used only to treat or prevent infections that are proven
More informationCubicin (Daptomycin) Priv.Doz. Dr. med. Markus Rothenburger
Cubicin (Daptomycin) Priv.Doz. Dr. med. Markus Rothenburger Cubicin (Daptomycin): A new generation of antibiotics First-in-class cyclic natural lipopeptide Activity against major gram positive pathogens
More informationSUPPLEMENTAL TESTING. Tan Thean Yen
SUPPLEMETAL TESTG Tan Thean Yen To Supplement Definition: add as a supplement to what seems insufficient "supplement your diet" Why supplement? urrent methods don t work well Additional information provided
More informationRISK ASSESSMENT CAMPYLOBACTER INFECTION TRANSMISSION FROM PIGS TO MAN USING ERYTHROMYCIN RESISTANCE AS A MARKER
RISK ASSESSMENT CAMPYLOBACTER INFECTION TRANSMISSION FROM PIGS TO MAN USING ERYTHROMYCIN RESISTANCE AS A MARKER D.G.S. BURCH Octagon Services Ltd, Old Windsor, Berks. SL4 2NR The Pig Journal (2002) 50,
More informationBest Practice of in vitro Methods on Measuring Anti Microbial of Chemical Substance on Root Canal Treatment: Literature Review
Best Practice of in vitro Methods on Measuring Anti Microbial of Chemical Substance on Root Canal Treatment: Literature Review Dani Rizali Firman 1, Indra Primathena 2 1 Oral Biology Department, Faculty
More informationNorth Carolina CRE Laboratory Task Force
North Carolina CRE Laboratory Task Force Carbapenem-Resistant Enterobacteriaceae (CRE) Screening and Confirmatory Testing Recommendations in North Carolina 2018 Consensus guidelines developed by the North
More informationThe CLSI Approach to Setting Breakpoints
The CLSI Approach to Setting Breakpoints Jean B. Patel, PhD, D(ABMM) Deputy Director, Office of Antimicrobial Resistance Division of Healthcare Quality Promotion National Center for Emerging and Zoonotic
More informationComparison of Minocycline Susceptibility Testing Methods for Carbapenem- Resistant Acinetobacter baumannii
JCM Accepted Manuscript Posted Online 14 September 2016 J. Clin. Microbiol. doi:10.1128/jcm.01810-16 Copyright 2016, American Society for Microbiology. All Rights Reserved. 1 2 Comparison of Minocycline
More informationCOMPARATIVE ANTI MICROBIAL STUDY OF SHUDDHA KASISA AND KASISA BHASMA
Research Article International Ayurvedic Medical Journal ISSN:2320 5091 COMPARATIVE ANTI MICROBIAL STUDY OF SHUDDHA KASISA AND KASISA BHASMA Dr. Nisha Kumari.P. R *Dr. Dinesh Nayak J **, Dr. Sathyanarayana
More informationBasic Concepts of PK/PD -pharmacodynamic indices- Johan W. Mouton MD PhD FIDSA Professor pharmacokinetics and pharmacodymamics
Basic Concepts of PK/PD -pharmacodynamic indices- Johan W. Mouton MD PhD FIDSA Professor pharmacokinetics and pharmacodymamics This patient needs antibiotics. But which ones? Intensive care patient Ceftazidime,
More informationReceived 31 March 2009/Returned for modification 26 May 2009/Accepted 22 June 2009
JOURNAL OF CLINICAL MICROBIOLOGY, Sept. 2009, p. 2766 2771 Vol. 47, No. 9 0095-1137/09/$08.00 0 doi:10.1128/jcm.00654-09 Copyright 2009, American Society for Microbiology. All Rights Reserved. Comparison
More information